To view or add a comment, sign in Canadian companies are ready to scale, and so are we
And to those people, I want to say its not your fault. The special also brought together for the first time two major competitors that are expanding the pharmaceutical weight loss drugs conversation: Negelle Morris, senior vice president, cardiometabolic sales of Novo Nordisk Inc., the Danish company behind Ozempic and Wegovy, and Rhonda Pacheco, group vice president of diabetes and obesity for Eli Lilly, the American pharma company that manufactures and sells Mounjaro and Zepbound
For research-grade peptides, The Peptide Guide highlights suppliers that provide: Third-party purity testing Certificate of Analysis (COA) for each batch Controlled manufacturing environments Proper cold-chain shipping practices Always verify independent laboratory testing before sourcing research peptides
Benefits & Results
Safety profiles for once-weekly Ozempic (semaglutide) injection and once-daily Ozempic pill (semaglutide) injection and once-daily Ozempic pill Safety and tolerability evaluated across clinical trials Rates of GI symptoms across placebo-controlled trials with Ozempic injection and semaglutide tablets 1,2,a The most common adverse reactions reported in 5% of patients taking Ozempic injection and Ozempic tablets are nausea, vomiting, diarrhea, abdominal pain, and constipation
Because standard medicine treats the symptoms